BioCentury | Mar 19, 2019
Distillery Therapeutics

RGMA protein to treat peritonitis

...in the peritoneum. Next steps could include testing RGMA in additional models of peritonitis. TARGET/MARKER/PATHWAY: RGM domain family member A (RGMA)...
...online Feb. 7, 2019 doi:10.1038/s41467-019-08328-5 CONTACT: Valbona Mirakaj, University Hospital Tübingen, Tübingen, Germany e-mail: valbona.mirakaj@uni-tuebingen.de Hongjiang Li RGM domain family member A (RGMA) Inflammation...
BioCentury | Oct 31, 2017
Distillery Techniques

Disease models

...in PD patients. Next steps could include using the model to screen for therapies. DESCRIPTION: RGM domain family member A (RGMA)-overexpressing...
...Sept. 27, 2017 doi:10.1523/JNEUROSCI.0084-17.2017 CONTACT: Joanna A. Korecka, McLean Hospital, Belmont, Mass. email: jkorecka@mclean.harvard.edu Hongjiang Li McLean Hospital RGM domain family member A (RGMA)...
BioCentury | Apr 21, 2011
Distillery Therapeutics

Indication: Inflammation

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Inflammation RGM domain family member A (RGMA) In vitro and mouse...
BioCentury | Mar 31, 2011
Distillery Therapeutics

Indication: Neurology

...in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Multiple sclerosis (MS) RGM domain family member A (RGMA)...
Items per page:
1 - 4 of 4